Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...

Bioequivalence studies: Biowaivers

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases.

Human mutation·2022

Same author

Does being exposed to an educational tool influence patient preferences? The influence of an educational tool on patient preferences assessed by a discrete choice experiment.

Patient education and counseling·2021

Same author

The case for open science: rare diseases.

JAMIA open·2021

Same author

Short-term mental distress in research participants after receiving cardiovascular risk information.

PloS one·2019

Same author

Values and value conflicts in implementation and use of preconception expanded carrier screening - an expert interview study.

BMC medical ethics·2019

Same author

Research participants' preferences for receiving genetic risk information: a discrete choice experiment.

Genetics in medicine : official journal of the American College of Medical Genetics·2019

Same journal

Mental health, normativity, and local knowledge in global perspective.

Studies in history and philosophy of biological and biomedical sciences·2020

Same journal

Signals without teleology.

Studies in history and philosophy of biological and biomedical sciences·2020

Same journal

Issues of biopolitics of reproduction in post-war Greece.

Studies in history and philosophy of biological and biomedical sciences·2020

Same journal

Resurecting raciology? Genetic ethnology and pre-1945 anthropological race classification.

Studies in history and philosophy of biological and biomedical sciences·2020

Same journal

Race science in Czechoslovakia: Serving segregation in the name of the nation.

Studies in history and philosophy of biological and biomedical sciences·2020

Same journal

Transfer of Lamarckisms and emerging 'scientific' psychologies: 19th - early 20th centuries Britain and France.

Studies in history and philosophy of biological and biomedical sciences·2020

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 5, 2026

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

Combining efficiency and concerns about integrity when using human biobanks.

Mats G Hansson¹

¹Centre for Bioethics at Karolinska Institutet and Uppsala University, Department of Public Health and Caring Sciences, Uppsala Science Park, SE-75185 Uppsala, Sweden. Mats.Hansson@bioethics.uu.se

Studies in History and Philosophy of Biological and Biomedical Sciences

|September 19, 2006

Summary

This summary is machine-generated.

Human bio-sampling law balances donor integrity and research efficiency. When donor information is protected and research is transparent, efficient biobank research can proceed without direct participant contact.

More Related Videos

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Creation and Maintenance of a Living Biobank - How We Do It

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

Related Experiment Videos

Last Updated: Jan 5, 2026

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Author Spotlight: Advancing Prostate Cancer Research Through Improved Tissue Sampling and Biobanking

Published on: November 17, 2023

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Creation and Maintenance of a Living Biobank - How We Do It

Creation and Maintenance of a Living Biobank - How We Do It

Published on: April 10, 2021

Area of Science:

Bioethics
Medical Law
Public Health

Background:

Debate exists between patient/donor interests and scientist research freedom regarding human bio-sampling.
Swedish biobank law (2003) reflects this perceived conflict.
Scientists require efficient access to biological samples; donors seek integrity protection.

Purpose of the Study:

To argue that donor integrity and research efficiency in bio-sampling are compatible.
To explore how understanding donor interests can align with research goals.
To propose conditions for efficient biobank research that respects donor rights.

Main Methods:

Legal and ethical analysis of human bio-sampling.
Examination of the Swedish biobank law.
Argumentation based on shared interests between donors and researchers.

Main Results:

The interests of donors and scientists in bio-sampling are not inherently opposed.
Donors have interests as both sample providers and end-users of research outcomes.
Efficient biobank research can be achieved while safeguarding donor integrity.

Conclusions:

When biobank research information is restricted to researchers, coded for secrecy, and democratically controlled, efficiency and integrity can coexist.
General information during sample collection may suffice without further participant contact.
This approach supports both scientific advancement and donor protection in bio-sampling.